Equillium EQ
NASDAQ EQ
$2.23 +0.01 (+0.68%)
As of: Sep 4, 2026 · 3:15 PM EDT

Equillium (EQ) Operating Income (2018 - 2026)

Equillium (EQ) posted quarterly Operating Income of -$5.6 million for Q1 2026, up 36.75% year-over-year from -$4.1 million in Q1 2025, and down 41.6% quarter-over-quarter from -$4.0 million in Q4 2025.

Analysis

Equillium (EQ) Operating Income (2018 - 2026) Analysis & Trends

Equillium (EQ) has reported Operating Income for 9 consecutive years, with -$5.6 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Operating Income rose 36.75% year-over-year to -$5.6 million; the TTM figure through Mar 2026 stood at -$20.4 million (down 42.02% YoY), while the FY2025 annual figure was -$23.6 million, down 185.81% from the prior year.
  • Operating Income slipped to -$5.6 million in Q1 2026 per EQ's latest filing, from -$4.0 million in the prior quarter.
  • Across five years, Operating Income topped out at $2.0 million in Q4 2022 and bottomed at -$37.3 million in Q1 2022.
  • Historically, Operating Income has averaged -$6.7 million across 5 years, with a median of -$4.1 million in 2023.
  • Annual changes were most pronounced in 2022 — Operating Income surged 119.66% — and 2025, when it tumbled 6128.0%.
  • Equillium's Operating Income stood at $2.0 million in 2022, then plunged by 256.71% to -$3.2 million in 2023, then slumped by 46.81% to -$4.7 million in 2024, then gained by 15.67% to -$4.0 million in 2025, then sank by 41.6% to -$5.6 million in 2026.
  • Business Quant data shows EQ's Operating Income at -$5.6 million in Q1 2026, -$4.0 million in Q4 2025, and -$4.6 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Vertex Pharmaceuticals 138.51 Bn 130.66 Bn 2.84 Bn 1.25 Bn
2 Regeneron Pharmaceuticals 85.24 Bn 77.25 Bn 3.93 Bn 1.29 Bn
3 Argenx Se 63.46 Bn 58.28 Bn 1.37 Bn 493.00 Mn
4 Moderna 57.89 Bn 52.75 Bn 52.00 Mn -815.00 Mn
5 Revolution Medicines 44.02 Bn 44.02 Bn - -505.13 Mn
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn 325.05 Mn
7 Alnylam Pharmaceuticals 35.49 Bn 32.19 Bn 992.69 Mn 231.44 Mn
8 Royalty Pharma 28.43 Bn 27.59 Bn - 133.12 Mn
9 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -1.55 Mn
10 Equillium 249.33 Mn 249.33 Mn - -5.16 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -5.16 Mn
Mar 31, 2026 -5.61 Mn
Dec 31, 2025 -3.96 Mn
Sep 30, 2025 -4.58 Mn
Jun 30, 2025 -6.23 Mn
Mar 31, 2025 -8.87 Mn
Dec 31, 2024 -4.70 Mn
Sep 30, 2024 -679,000.00
Jun 30, 2024 -100,000.00
Mar 31, 2024 -2.79 Mn
Dec 31, 2023 -3.20 Mn
Sep 30, 2023 -3.62 Mn
Jun 30, 2023 -3.59 Mn
Mar 31, 2023 -4.11 Mn
Dec 31, 2022 2.04 Mn
Sep 30, 2022 -13.24 Mn
Jun 30, 2022 -13.55 Mn
Mar 31, 2022 -37.33 Mn
Dec 31, 2021 -10.39 Mn
Sep 30, 2021 -9.86 Mn